Mumps

[unable to retrieve full-text content] Oregon's COVID-19 emergency declaration ending, no impact on OHP coverage    Ontario Argus Observer

Dr. Daniel Leonard is a pediatrician in Hastings, Nebraska. (Patient pictured here is not a Moderna trial participant.) Courtesy of Meridian Clinical Research One of the pediatricians trialing Moderna's vaccine for kids 0-6 spoke with Insider about the symptoms he's seen. Kids in his trial haven't had arm pain or many other tell-tale s...

[unable to retrieve full-text content] Study: Pro-vaccine ad featuring Trump led to bump in COVID-19 shots    TribDem.com

Effective immediately , the federally mandated 21st Century Cures Act requires enrollment for all Medicaid managed care network health care professionals. MassHealth is enforcing the enrollment requirement. If your enrollment with the state Medicaid agency is missing or expired, your participation is at risk of being removed from UnitedHealthcare Community Plan of Massachusetts Senior Care Options and Connected for One Care. By complying with the Cures Act and having a current MassHealth enrollment, you'll help maintain your network participation and avoid billing delays.   Next steps UnitedHealthcare will send you a provider notice letter letting you know that you will need to enroll in MassHealth to obtain a Medicaid ID. When you receive this notice, please act immediately. If action is required Complete the MassHealth contract. This means you'll now have 2 different, active contracts: Note: Enrolling doesn't mean you're required to delive...

Tetanus, diphtheria, and pertussis (Tdap) are infectious bacterial diseases. Without treatment, they can lead to severe complications, and in some instances, they are fatal. The Tdap vaccine protects against all three diseases. The Tdap vaccine is highly effective. Since the introduction of vaccines, cases of diphtheria and tetanus have dropped by 99% , while cases of pertussis have dropped by 80%. Doctors can give Tdap as a primary immunization or as a booster vaccine, meaning it "tops up" the immunity a person already has to an illness. In this article, we will discuss what the Tdap vaccine is, how safe it is, who should get it, and possible side effects. Tdap is a booster vaccine. It protects people from the following illnesses. Tetanus Tetanus is an infectious disease due to bacteria in soil and feces. These microbes can enter the body through cuts and wounds. When they begin to multiply, they produce a toxin that causes painful muscle contractions and spasms. These contr...

National vaccination coverage for kindergarteners during the 2020-2021 school year fell below the nationwide target of 95% coverage, according to a new Centers for Disease Control and Prevention analysis. This includes MMR, DTaP and varicella vaccines, which protect against multiple diseases including measles, mumps, rubella, chicken pox, whooping cough, tetanus and chickenpox. The analysis did not include COVID-19 vaccines, which were authorized for children 5 and older after the end of the 2020-2021 school year. Although the drop was small -- down to 94%, representing a 1% drop from the prior school year -- the CDC says the new analysis underscores growing concerns that pandemic disruptions could inadvertently lead to a growing number of vaccine-preventable illnesses among children. "This might not sound like much, but it amounts to at least 35,000 more children across the United States that entered kindergarten without documentation of complete vaccinations against common disea...

TIANJIN , April 3, 2022 /PRNewswire/ -- CanSino Biologics Inc. ("CanSinoBIO" of "the Company") (SSE: 688185, HKEX: 06185) today announced that the National Medical Products Administration of China ("NMPA") granted approval for the clinical trial application of its COVID-19 mRNA vaccine in China . Pre-clinical trial results showed that CanSinoBIO's COVID-19 mRNA vaccine can induce high-titer neutralizing antibody levels against multiple SARS-CoV-2 variants of concern ("VOC") identified by the World Health Organization ("WHO"), including the Omicron variant, a highly transmissible and the most dominant strain circulating in China and globally. Additionally, results showed that CanSinoBIO's mRNA vaccine can induce neutralizing antibodies with greater cross-reactivity against global VOCs and provide stronger protection against infections caused by the circulating variants, compared to the original strain-based COVID-19...